funded by the Emergency Response Mechanism Operation Program of China CDC(102393220020010000017).
What is already known about this topic?From 2010 to 2012,the incidence of adverse vaccine reactions from meningococcal vaccine(MenV)in China ranged from 8.46 to 56.30 per 100,000 doses.What is added by this report?Fro...
Supported by the National Natural Science Foundation of China(Project Nos.82473732 to Fang Shao,82404383 to Mengyi Lu,82173620 and 82373690 to Yang Zhao,and 82204156 to Dongfang You);Additional funding was provided through the Priority Academic Program Development of Jiangsu Higher Education Institutions(PAPD);The study also received partial support from the Bill&Melinda Gates Foundation(Project No.INV-006371 to Feng Chen).
Introduction:The cost-effectiveness of vaccination strategies plays a crucial role in managing infectious diseases such as influenza within public health systems.This study evaluated the cost-effectiveness of vaccinat...
What is already known about this topic?Pregnancy is associated with increased risk for severe illness and complications attributable to influenza infection.Information about the incidence of influenza hospitalization ...
Supported by the National Natural Science Foundation of China[No.71874034(Dr Hou)];the Soft Science Research Project of Shanghai“Science and Technology Innovation Action Plan”[No.22692107600(Dr Hou)].
What is already known about this topic?The significant disparities in global coronavirus disease 2019(COVID-19)vaccine coverage hamper the pace of epidemic control.There is a need to better understand the factors cont...
Supported by the National Key Research and Development Program(SQ2022YFC3600291)and the Population and Aging Health Science Program(WH10022023035).
Summary What is already known about this topic?Meningitis,a life-threatening disease,presents a significant public health challenge.Its rate of progress in burden reduction notably lags behind other diseases that can ...
What is already known about this topic?The coronavirus disease 2019(COVID-19)persists as a significant global public health crisis.The predominant strain,severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),not...
This study was supported by the National Key Research and Development Program of China(2021YFC2301604);the Young Elite Scientists Sponsorship Program by CAST(2022QNRC001);Emergency Grants for Prevention and Control of SARS-CoV-2 in Guangdong Province(2022A1111090004);the Science and Technology Program of Guangzhou(202102021285).
Summary What is already known about this topic?A considerable percentage of the population has received both primary and booster vaccinations,which could potentially provide protection against severe acute respiratory...
Supported by the China Association for Science and Technology(Project Number:2021ZZKCB082026);Bill&Melinda Gates Foundation(Project Number:INV-023808).
Summary What is already known about this topic?Public health workers(PHWs)were listed as a priority group recommended for influenza vaccination during the coronavirus disease 2019(COVID-19)pandemic.Understanding the d...
Supported by National Natural Science Foundation of China(81872674),and Four“Batches”Innovation Project of Invigorating Medical through Science and Technology of Shanxi Province(2022XM45).
Summary What is already known about this topic?Although a third coronavirus disease 2019(COVID-19)vaccination(booster)dose is highly recommended for diabetic patients,the vaccination behaviors and related adverse even...
Supported by the Capital’s Funds for Health Improvement and Research(2021-1G-3011).
Introduction:Oral fluids(OFs)have been broadly used as non-invasive samples for evaluating protective IgG antibodies from natural infection or vaccination,especially in pediatric populations.Methods:Paired OF and seru...